Free Trial

ALX Oncology (ALXO) SEC Filings & 10K Form

ALX Oncology logo
$0.53 -0.01 (-2.56%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$0.53 +0.01 (+1.29%)
As of 07/25/2025 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ALX Oncology SEC Filings

DateFilerForm TypeView
07/08/2025
3:37 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:35 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2025
11:15 PM
ALX Oncology (Filer)
Form EFFECT
04/21/2025
4:19 PM
ALX Oncology (Filer)
Form ARS
04/15/2025
3:29 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:45 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:41 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:26 PM
ALX Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/21/2025
3:20 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:23 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:27 PM
ALX Oncology (Issuer)
Takimoto Chris H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:29 PM
ALX Oncology (Issuer)
GOODMAN COREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:30 PM
ALX Oncology (Issuer)
Garland J. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:32 PM
ALX Oncology (Issuer)
Hemrajani Rekha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:14 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:17 PM
ALX Oncology (Issuer)
Shantharam Harish (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2025
5:19 PM
ALX Oncology (Issuer)
Shantharam Harish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:22 PM
ALX Oncology (Issuer)
Klencke Barbara (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2025
5:24 PM
ALX Oncology (Issuer)
Klencke Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:25 PM
ALX Oncology (Issuer)
Takimoto Chris H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2025
5:07 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:09 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:11 PM
ALX Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:01 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
3:39 PM
ALX Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/17/2025
3:41 PM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:10 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:43 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:46 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:12 PM
ALX Oncology (Subject)
Form SC TO-I/A
12/27/2024
3:05 PM
ALX Oncology (Subject)
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
Form SCHEDULE 13G
12/06/2024
10:33 AM
ALX Oncology (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
12/02/2024
3:06 PM
ALX Oncology (Subject)
Form SC TO-I
11/14/2024
6:22 PM
ALX Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
11/14/2024
5:58 PM
ALX Oncology (Subject)
Vivo Capital Fund IX, L.P. (Filed by)
Form SC 13G/A
11/14/2024
2:02 PM
ALX Oncology (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G/A
11/14/2024
7:03 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
3:14 PM
ALX Oncology (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
10/04/2024
8:00 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
3:00 PM
ALX Oncology (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
08/16/2024
4:05 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Genesis 14:13-17 [HIDDEN MEANING?] (Ad)

A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century. Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available.

Watch the presentation on America’s hidden birthright
08/16/2024
4:06 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:08 PM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:09 PM
ALX Oncology (Issuer)
Randolph Sophia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:10 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:17 PM
ALX Oncology (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
08/07/2024
4:23 PM
ALX Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:22 PM
ALX Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2024
3:45 PM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALXO) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners